[Safety and immunogenicity analysis of recombinant (hansenula polymorpha) hepatitis B vaccine (CpG ODN adjuvant) among adults: the preliminary results of phase I clinical trial]
zhonghua yu fang yi xue za zhi [chinese journal of preventive medicine]2020Vol. 54pp. -
312
zz2020zhonghua[safety
Abstract
Objective: To evaluate the safety and immune effect of recombinant hepatitis B vaccine (CpG ODN adjuvant). Methods: On Oct. 26, 2016, we launched volunteer recruitment in Kaihua county, Quzhou city, Zhejiang Province. In the randomized, double-blind, controlled trial, a total of 48 sub …